These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 556348)

  • 1. Antitumor activity of methyl 1-(5-fluoro-1H-2-oxopyrimidin-4-yl)-beta-D-glucopyranuronate against murine leukemia L1210.
    Shimizu F; Arakawa M
    Gan; 1978 Oct; 69(5):667-71. PubMed ID: 556348
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor activity of 1-alkylcarbamoyl derivatives of 5-fluorouracil against L1210 leukemia.
    Hoshi A; Iigo M; Nakamura A; Inomata M; Kuretani K
    Chem Pharm Bull (Tokyo); 1978 Jan; 26(1):161-5. PubMed ID: 639159
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor activity of carbamoyl derivatives of 5-fluorouracil by oral administration.
    Hoshi A; Iigo M; Yoshida M; Kuretani K
    Gan; 1975 Dec; 66(6):673-4. PubMed ID: 1225720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with cyclophosphamide and ftorafur against advanced L1210 murine leukemia.
    Grossie VB; Rosenblum MG; Loo TL
    Cancer Treat Rep; 1982 Aug; 66(8):1631-4. PubMed ID: 6809329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of benzoyl and benzenesulfonyl derivatives of 5-fluorouracil.
    Hoshi A; Iigo M; Nakamura N; Kuretani K
    Gan; 1974 Oct; 65(5):463. PubMed ID: 4435343
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antitumor activity of 1- or 3-(alpha-hetero substituted)alkyl-5-fluorouracil derivatives.
    Ozaki S; Nagase T; Ahmad S; Tamai H; Hoshi A; Iigo M
    Nucleic Acids Symp Ser; 1987; (18):1-4. PubMed ID: 3697106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors.
    Hoshi A; Iigo M; Nakamura A; Yoshida M; Kuretani K
    Gan; 1976 Oct; 67(5):725-31. PubMed ID: 1017587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor activity of 1-acyloxymethyl derivatives of 5-fluorouracil against L1210 leukemia.
    Hoshi A; Inomata M; Kanzawa F; Iigo M; Kuretani K
    J Pharmacobiodyn; 1982 Mar; 5(3):208-12. PubMed ID: 7097489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activity of 5-fluorouracil derivatives.
    Ozaki S
    Med Res Rev; 1996 Jan; 16(1):51-86. PubMed ID: 8788214
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enhanced antitumor action of 5-fluorouracil when used in combination with 4-methylmercaptopyrazolo[3,4-d]pyrimidine 1-nucleoside].
    Lobova TG; Korbukh IA; Preobrazhenskaia MN; Garin AM
    Eksp Onkol; 1988; 10(4):69-71. PubMed ID: 3181079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antileukemic effect in combination of 5-fluorouracil and OK-432.
    Koshimura S; Ryoyama K
    Cancer Treat Rep; 1977; 61(1):17-27. PubMed ID: 324619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of 5-fluorouracil in combination with some additives which stimulate the formation of antineoplastic 5-fluorouracil nucleotides.
    Tamemasa O; Tezuka M
    Gan; 1983 Apr; 74(2):285-90. PubMed ID: 6407888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V; Cernochová S
    Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: A comparison of the cell killing in the mouse after exposure to ftorafur and to 5-fluorouracil.
    Van Putten LM; Kram-Idsenga LK; Pijpers-de Bruin M
    Br J Cancer; 1974 Aug; 30(2):179-80. PubMed ID: 4419296
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW; Cheng YC; Schabel FM; Montgomery JA
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T; Akahori Y; Sakurai Y
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vivo antitumor activity of potential 5-fluorouracil prodrugs.
    Rosowsky A; Kim SH; Trites D; Wick M
    J Med Chem; 1982 Sep; 25(9):1034-40. PubMed ID: 7131481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.